GSK-111375

Study Sponsor: GSK

Study Title

Follow-up study to evaluate the long-term immunogenicity and safety of a HPV vaccine (580299) in healthy female subjects

Medicine or Vaccine (generic name)

Human Papillomavirus Types 16 and 18 Vaccine

Sponsor Identification Number

111375

Trial Registry Identification Number(#'s)

NCT00877877 2008-000369-44

Medical Condition

Infections, Papillomavirus

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=111375

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00877877

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-000369-44

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 580299/013. The results of 580299/013 are summarised with studies 104896 (M18), 104902 (M24), 104904 (M36) and 104918 (M48) on the GSK Study Register

Date Added to this Site

June 2015